Silent diffuse low-grade glioma: Toward screening and preventive treatment?

67Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We show that people with a silent glioma have more chances to die from their gliomas than from another unrelated cause. This result, combined with the knowledge that diffuse low-grade gliomas remain clinically silent for a very long period (>10 years), grounds the screening and preventive treatment of silent diffuse low-grade glioma. © 2014 American Cancer Society.

Cite

CITATION STYLE

APA

Mandonnet, E., De Witt Hamer, P., Pallud, J., Bauchet, L., Whittle, I., & Duffau, H. (2014, June 15). Silent diffuse low-grade glioma: Toward screening and preventive treatment? Cancer. John Wiley and Sons Inc. https://doi.org/10.1002/cncr.28610

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free